Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group.
AuthorsIllidge, Timothy M
AffiliationInstitute of Cancer Sciences, University of Manchester, Manchester Academic Health Sciences Centre, The Christie National Health Service Foundation Trust, Manchester, United Kingdom.
MetadataShow full item record
AbstractRadiation therapy (RT) is the most effective single modality for local control of non-Hodgkin lymphoma (NHL) and is an important component of therapy for many patients. Many of the historic concepts of dose and volume have recently been challenged by the advent of modern imaging and RT planning tools. The International Lymphoma Radiation Oncology Group (ILROG) has developed these guidelines after multinational meetings and analysis of available evidence. The guidelines represent an agreed consensus view of the ILROG steering committee on the use of RT in NHL in the modern era. The roles of reduced volume and reduced doses are addressed, integrating modern imaging with 3-dimensional planning and advanced techniques of RT delivery. In the modern era, in which combined-modality treatment with systemic therapy is appropriate, the previously applied extended-field and involved-field RT techniques that targeted nodal regions have now been replaced by limiting the RT to smaller volumes based solely on detectable nodal involvement at presentation. A new concept, involved-site RT, defines the clinical target volume. For indolent NHL, often treated with RT alone, larger fields should be considered. Newer treatment techniques, including intensity modulated RT, breath holding, image guided RT, and 4-dimensional imaging, should be implemented, and their use is expected to decrease significantly the risk for normal tissue damage while still achieving the primary goal of local tumor control.
CitationModern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. 2014, 89 (1):49-58 Int. J Radiat Oncol Biol Phys
JournalInternational Journal of Radiation Oncology, Biology, Physics
- Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
- Authors: Specht L, Yahalom J, Illidge T, Berthelsen AK, Constine LS, Eich HT, Girinsky T, Hoppe RT, Mauch P, Mikhaeel NG, Ng A, ILROG.
- Issue date: 2014 Jul 15
- Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
- Authors: Koeck J, Abo-Madyan Y, Lohr F, Stieler F, Kriz J, Mueller RP, Wenz F, Eich HT
- Issue date: 2012 May 1
- Recommendations for the use of radiotherapy in nodal lymphoma.
- Authors: Hoskin PJ, Díez P, Williams M, Lucraft H, Bayne M, Participants of the Lymphoma Radiotherapy Group.
- Issue date: 2013 Jan
- Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
- Authors: Specht L
- Issue date: 2016 Jan
- Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.
- Authors: Yahalom J, Illidge T, Specht L, Hoppe RT, Li YX, Tsang R, Wirth A, International Lymphoma Radiation Oncology Group.
- Issue date: 2015 May 1